FormaPharm Engineering

What FormaPharm Engineering does

FormaPharm Engineering Group LLC is a privately held pharmaceutical engineering and construction services firm founded in December 1993 in Belgrade, Serbia, where it remains headquartered at Čarlija Čaplina 36. The company delivers integrated Engineering, Procurement, Construction, and Validation (EPC/EPCV) services for GMP-compliant pharmaceutical manufacturing facilities, with in-house capabilities spanning conceptual and detailed design, orbital welding of stainless steel process pipelines (PW, WFI, clean steam, technical gases), cleanroom construction (including ISO 8 classified environments), HVAC, BMS/EMS automation, mechanical and electrical installation, commissioning, and full CQV documentation (URS, DQ, IQ, OQ, PQ, VMP, SOPs). A 700 m² owned workshop in Vršac, Serbia supports prefabrication, and the firm holds multiple orbital welding stations (ORBITEC 3, ORBITEC 4, ORBITEC tigtronic 205) and ESAB TIG 1500 manual welding units.

The business serves enterprise pharmaceutical manufacturers — including STADA/Hemofarm, Bosnalijek, Sopharma, Vimedimex, Soteks, West Pharmaceutical Services, Torlak Institute, NiaMedik, and Hemomont — through project-based contracts priced via unit-price, percentage-of-readiness, fixed-price, turnkey EPC/EPCV, contractor-only, materials procurement, or target-cost models. The firm also operates a wholly-owned subsidiary in Obninsk, Russia, and regional entities in Croatia, Bosnia and Herzegovina, and North Macedonia, alongside consortium partnerships (notably with Center for Architecture and Urbanism for Montenegro projects). Approximately 50 multidisciplinary specialists support delivery across 250 projects spanning Serbia, Russia, Vietnam, Bulgaria, Bosnia and Herzegovina, Croatia, North Macedonia, Montenegro, Romania, China, Germany, Saudi Arabia, Ukraine, Cyprus, and the UK, with active certifications in ISO 9001, ISO 14001, ISO 45001, EU GMP consulting capability, and Russian design/construction licensing.

FormaPharm was acquired by its current owner Oliver Stanković in September 2012 (formerly Hemofarm Inženjering d.o.o.) and underwent international expansion thereafter. New verticals under active delivery include regulated medical cannabis cultivation/processing facilities and molecular diagnostic laboratories. Leadership was refreshed in 2023 with Maksim Rakuš appointed Director, followed by the promotion of Nenad Nišević to Director of Engineering. The company markets primarily through relationship-driven direct enterprise sales, a multilingual website (English, Serbian, German, Russian), and project-referral channels.

Name

FormaPharm Engineering

Legal name

FormaPharm Engineering Group LLC

Website

https://formapharm.net

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

101–250 employees

Short description

FormaPharm Engineering Group is a Belgrade-based engineering and construction firm founded in 1993 that delivers EPC/EPCV turnkey services — design, cleanroom construction, orbital welding, process fluid systems, HVAC, and CQV validation — to pharmaceutical manufacturers across Southeast Europe, Russia, and emerging Asian markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Engineering Services

NAICS

Architectural, Engineering, and Related Services (5413)

SIC

Services-Engineering Services (8711)

akta.pro primary industry

Design-Build / EPC General Contracting (IMAFAAAD)

Keywords

• Pharmaceutical engineering services
• Cleanroom construction services
• Orbital welding services
• GMP qualification validation
• Pharmaceutical EPC services

Headquarters

HQ city

Belgrade

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Engineering and Project Consulting: Pre-project consulting including feasibility studies, project definition, risk assessment, quality assessment, and audit services. Billed through project contracts or on a consulting retainer basis.
2. Engineering Design Services: Conceptual, basic (idejni), and detailed (izvođački) project design for pharmaceutical facilities, cleanrooms, HVAC, process fluid systems, automation. Provided as standalone services or bundled within EPC contracts.
3. EPC / Turnkey Project Delivery: Full Engineering, Procurement, Construction (EPC) and EPC with Validation (EPCV) contracts covering project delivery from concept to commissioning. Multiple contracting models are offered: unit-price, percentage-of-readiness, fixed-price, turnkey, contractor-only, materials-only, and target-cost contracts. Revenue recognized upon project completion.
4. Construction and Installation Works: On-site construction and installation services including mechanical installations, HVAC, orbital welding, cleanroom construction and equipment installation. Performed by in-house workshop facility in Vršac (700 m²) and on-site teams.
5. Qualification and Validation (CQV) Services: Commissioning, qualification, and verification services (CQV) including IQ, OQ, PQ protocols, GMP regulatory consulting, and ongoing compliance support. Provided as part of EPCV contracts or as standalone consulting engagements.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

FormaPharm Engineering Group provides end-to-end engineering, procurement, construction, and validation (EPCV) services for pharmaceutical and adjacent regulated-industry manufacturers. Core deliverables include conceptual and detailed facility design, orbital welding of stainless steel process piping, cleanroom and HVAC installation, purified water and process fluid systems, BMS/EMS automation, and full CQV (IQ/OQ/PQ) qualification against EU GMP, FDA, and ISPE standards. The firm also offers standalone consulting for feasibility studies, audits, and regulatory compliance, with project delivery through flexible contracting models including fixed-price, turnkey, and target-cost contracts.

Product overview

FormaPharm Engineering Group is an international engineering services company founded in 1993, headquartered in Belgrade, Serbia, offering comprehensive services primarily for the pharmaceutical industry and other sectors. The company operates a platform-plus-services model, providing end-to-end engineering solutions from conceptual design through construction, installation, and validation. Key service offerings include Engineering Services, Orbital Welding Services, Consulting Services, Workshop Facility operations, Clean Room Systems, HVAC Systems, Process Fluid Systems, Automation Systems (BMS/EMS), Qualification and Validation Services, and EPC/EPCV turnkey project delivery. With over 32 years of experience and approximately 250 projects delivered, the company serves clients across Europe, Asia, Middle East, and Africa through subsidiaries in Serbia, Russia, Croatia, Bosnia and Herzegovina, Montenegro, and North Macedonia.

Differentiator

Problem solved

Functional benefit

Products and services

• EPCV (Engineering, Procurement, Construction and Validation) Services Turnkey EPCV project delivery from conceptual design through detailed engineering, procurement, construction, commissioning, qualification (IQ/OQ/PQ), and validation (CQV) for pharmaceutical, food, biotech, and medical device industries. For enterprise pharmaceutical manufacturers needing single-point-of-responsibility contracting.
• Engineering Design Services Conceptual, basic (idejni), and detailed (izvođački) project design for pharmaceutical facilities, cleanrooms, HVAC, process fluid systems, and automation. Available as a standalone service or bundled within EPCV contracts.

Quantifiable outcome

• 250 projects delivered across multiple continents over 32 years
• +4 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered major and core.

• HemomontmajorStrategic or Co-development Partner · 22 March 2024Hemomont is the first drug factory in Montenegro and a member of the Hemofarm and STADA group. FormaPharm (with consortium partner CAU) provides design, construction, and installation services for Hemomont facilities, including the SNUP (sterile nasal spray) production department and warehouse. Long-term ongoing relationship spanning multiple projects.
• Center for Architecture and Urbanism (CAU)coreChannel Partner/ Reseller/ Distributor · 1 January 2024CAU is a consortium partner working with FormaPharm on projects in Montenegro, particularly with Hemomont. The FPEG + CAU consortium has successfully completed design and construction work on the SNUP (sterile nasal spray) production facility at Hemomont in Podgorica. The consortium combines architecture and engineering capabilities for integrated project delivery.
• SGScoreOthers · 1 January 2022SGS is a leading global inspection, evaluation, and certification company. FormaPharm undergoes annual ISO 9001 (QMS), ISO 14001 (EMS), and ISO 45001 (OHS) recertification and surveillance audits through SGS. The certification relationship confirms FormaPharm's management system compliance with international standards.
• AmeriPharmmajorStrategic or Co-development Partner · 24 July 2020AmeriPharm is the investor in a medical cannabis growing and processing facility in North Macedonia. FormaPharm signed a multimillion-dollar contract for mechanical installations and HVAC systems at this facility, which will have the largest capacity for growing plants in controlled conditions in Southeast Europe (approximately 10,000 m², including ISO8 classified cleanrooms for processing and extraction).
• Vimedimex Group / Vimedimex 2 Pharmaceutical JSCmajorStrategic or Co-development Partner · 2 July 2020Vimedimex 2 Pharmaceutical JSC is a Vietnamese pharmaceutical manufacturer established by the Vimedimex Group to produce cancer drugs from local Vietnamese raw materials, targeting 70% market share of cancer drug groups L01 and L02 in Vietnam. FormaPharm provides multimillion-dollar consultancy, qualification, and validation services for the construction of a EU-GMP pharmaceutical manufacturing facility producing Non-Betalactam, Cephalosporin and Penicillin drugs. Total facility area approximately 23,000 m².
• Hemofarm A.D. (STADA)majorStrategic or Co-development Partner · 1 January 2020Hemofarm is a major pharmaceutical manufacturer under STADA Group, with facilities in Vršac, Šabac, and Banja Luka. FormaPharm has a longstanding relationship performing engineering, orbital welding, cleanroom installation, and purified water system work across Hemofarm sites. Multiple project engagements over decades.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Pharmadule Morimatsu: Pharmadule Morimatsu delivers modular and stick-built pharmaceutical facility EPC services with deep GMP cleanroom and process utility expertise. Comparable to FormaPharm's turnkey EPCV approach for API, solid dosage, and sterile facilities, particularly for emerging-market clients seeking international-grade design execution.
• Exyte Group: Exyte (formerly M+W Group) is a global EPCM specialist for high-tech industries including pharmaceuticals, biotech, and semiconductors. Most directly comparable to FormaPharm in offering full cleanroom, process utility, and facility delivery under a single accountable partner model, but at vastly larger scale across Western Europe, US, and Asia.
• Zeton Inc. Zeton designs and builds modular pilot plants and demonstration/small-scale production units for pharma, biotech, and process industries. Comparable to FormaPharm in specialized construction capability for regulated facilities, but differentiated by a modular fabrication focus versus FormaPharm's stick-built EPCV model.
• IPS (Integrated Project Services): IPS is a leading pharma engineering, construction, and validation firm serving regulated manufacturing clients globally. Overlaps directly with FormaPharm in GMP facility design, CQV, and process utility delivery, with a larger US-centric footprint and stronger presence in large-molecule and cell/gene therapy facilities.
• DPS Group: DPS Group is an engineering and EPCMV firm focused on advanced manufacturing facilities including pharma, biotech, medtech, and food. Highly comparable to FormaPharm in providing concept-to-validation services with strong regulatory (GMP/FDA) credentials and a project-based contracting model.
• NNE A/S: NNE (formerly Novo Nordisk Engineering) is a pharma engineering specialist delivering facility design, process, and validation services to insulin and biologics manufacturers. Direct peer to FormaPharm in regulated-facility engineering with a focus on aseptic and biologics production, particularly in Europe.
• CRB: CRB provides engineering, architecture, and construction services for life sciences and advanced technology clients, with deep GMP and FDA compliance expertise. Comparable to FormaPharm's integrated EPCV delivery for pharmaceutical and biotech facilities, though operating primarily across North America and Western Europe.

Broad incumbents

• Bilfinger: Bilfinger is an industrial services provider with engineering, maintenance, and construction capabilities across process industries including pharma and chemicals. Comparable to FormaPharm in facility construction and process utility work, particularly in European markets, though operating at much larger scale and across multiple industrial verticals.
• Fluor Corporation: Fluor is a global EPC firm with a life sciences and advanced manufacturing practice delivering large-scale pharma and biotech facilities. Overlaps with FormaPharm in regulated-facility construction and validation, but competes at the upper end of project size and in geographies where FormaPharm does not operate.
• Jacobs Solutions: Jacobs is a global professional services and EPC firm with a significant life sciences practice covering pharma, biotech, and consumer health. Larger and broader than FormaPharm, with overlap in pharma facility engineering and CQV work delivered across Western markets where FormaPharm is not currently active.

Market position

Weaknesses5 records

Competitive moat5 records

Key highlights6 records

Customer concentration

• Xx.com/formapharmd
• Facebookfacebook.com/FormaPharm.Group
• LinkedInlinkedin.com/company/formapharm-engineering-group

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FormaPharm Engineering